Bioscience Animal Valuation
| BIS Stock | 2.78 0.02 0.72% |
Based on Macroaxis valuation methodology, the firm appears to be overvalued. Bioscience Animal Health shows a prevailing Real Value of USD2.36 per share. The current price of the firm is USD2.78. Our model approximates the value of Bioscience Animal Health from analyzing the firm fundamentals such as Return On Equity of 0.12, profit margin of 0.03 %, and Current Valuation of 2.37 B as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Bioscience Animal's price fluctuation is unstable at this time. Calculation of the real value of Bioscience Animal Health is based on 3 months time horizon. Increasing Bioscience Animal's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Bioscience Animal's intrinsic value may or may not be the same as its current market price of 2.78, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.78 | Real 2.36 | Hype 2.78 |
The intrinsic value of Bioscience Animal's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Bioscience Animal's stock price.
Estimating the potential upside or downside of Bioscience Animal Health helps investors to forecast how Bioscience stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bioscience Animal more accurately as focusing exclusively on Bioscience Animal's fundamentals will not take into account other important factors: Bioscience Animal Total Value Analysis
Bioscience Animal Health is currently projected to have takeover price of 2.37 B with market capitalization of 2.75 B, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Bioscience Animal fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
2.37 B | 2.75 B |
Bioscience Animal Asset Utilization
One of the ways to look at asset utilization of Bioscience is to check how much profit was generated for every dollar of assets it reports. Bioscience Animal Health utilizes its assets nearly 0.0444 percent, earning 0.0444 cents for each dollar of assets held by the firm. An expanding asset utilization signifies that the company is being more effective with each dollar of assets it shows. Put another way, asset utilization of Bioscience Animal shows how effective it operates for each dollar spent on its assets.Bioscience Animal Ownership Allocation
Bioscience Animal holds a total of 314 Million outstanding shares. Bioscience Animal Health shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 84.04 percent of Bioscience Animal Health outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.About Bioscience Animal Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Bioscience Animal Health. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Bioscience Animal Health based exclusively on its fundamental and basic technical indicators. By analyzing Bioscience Animal's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Bioscience Animal's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Bioscience Animal. We calculate exposure to Bioscience Animal's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Bioscience Animal's related companies.8 Steps to conduct Bioscience Animal's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Bioscience Animal's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Bioscience Animal's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Bioscience Animal's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Bioscience Animal's revenue streams: Identify Bioscience Animal's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Bioscience Animal's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Bioscience Animal's growth potential: Evaluate Bioscience Animal's management, business model, and growth potential.
- Determine Bioscience Animal's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Bioscience Animal's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Other Information on Investing in Bioscience Stock
Bioscience Animal financial ratios help investors to determine whether Bioscience Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bioscience with respect to the benefits of owning Bioscience Animal security.